Co-evolution of matrisome and adaptive adhesion dynamics drives ovarian cancer chemoresistance
Platinum chemotherapy is standard of care in ovarian cancers but treatment resistance commonly develops. Here, the authors show that the extracellular microenvironment is modulated following chemotherapy and the changes in matrix proteins and stiffness alter the cell death response of tumour cells.
Saved in:
Main Authors: | Elina A. Pietilä, Jordi Gonzalez-Molina, Lidia Moyano-Galceran, Sanaz Jamalzadeh, Kaiyang Zhang, Laura Lehtinen, S. Pauliina Turunen, Tomás A. Martins, Okan Gultekin, Tarja Lamminen, Katja Kaipio, Ulrika Joneborg, Johanna Hynninen, Sakari Hietanen, Seija Grénman, Rainer Lehtonen, Sampsa Hautaniemi, Olli Carpén, Joseph W. Carlson, Kaisa Lehti |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/67c04582b2c44334b40a53907f9099c4 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Aggressive and recurrent ovarian cancers upregulate ephrinA5, a non-canonical effector of EphA2 signaling duality
by: Joonas Jukonen, et al.
Published: (2021) -
Proteome-wide and matrisome-specific alterations during human pancreas development and maturation
by: Zihui Li, et al.
Published: (2021) -
Tissue, age, sex, and disease patterns of matrisome expression in GTEx transcriptome data
by: Tim O. Nieuwenhuis, et al.
Published: (2021) -
FHOD1, a formin upregulated in epithelial-mesenchymal transition, participates in cancer cell migration and invasion.
by: Maria Gardberg, et al.
Published: (2013) -
Activin-mediated alterations of the fibroblast transcriptome and matrisome control the biomechanical properties of skin wounds
by: Mateusz S. Wietecha, et al.
Published: (2020)